ESCALON MEDICAL CORP (ESMC)
2025-03-31 | 2024-12-31 | 2024-09-30 | ||
|---|---|---|---|---|
| Revenues, net | - | 3,220,556 | - | |
| Marketing, general and administrative | - | 1,162,137 | 1,099,254 | |
| Research and development | - | 155,940 | 140,859 | |
| Cost of goods and services sold | - | 1,646,575 | 1,568,188 | |
| Total costs and expenses | - | 2,964,652 | 2,808,301 | |
| Revenue, net | - | - | 2,781,346 | |
| Operating income (loss) | - | 255,904 | -26,955 | |
| Interest expense, debt | - | 4,883 | 5,262 | |
| Other nonoperating expense | - | 5,000 | - | |
| Nonoperating income (expense) | - | - | -5,262 | |
| Net income (loss) | 271,472 | 246,021 | -32,217 | |
| Preferred stock dividends, income statement impact | 12,689 | 12,970 | 12,970 | |
| Undistributed earnings (loss) allocated to participating securities, basic | 123,323 | 110,327 | - | |
| Net income (loss) available to common stockholders, basic | 135,460 | 122,724 | -45,187 | |
| Basic eps | 0.02 | 0.02 | -0.01 | |
| Diluted eps | 0.02 | 0.02 | -0.01 | |
| Basic average shares | 7,415,329 | 7,415,329 | 7,415,329 | |
| Diluted average shares | 14,166,217 | 14,081,616 | 7,415,329 | |